Skip to content
Twitter page opens in new windowLinkedin page opens in new windowInstagram page opens in new window
investorenquiries@pharmaust.com+61 8 9202 6814
PharmAust (PAA)
Cancer Therapeutics Research
PharmAust (PAA)
  • HOME
  • ABOUT
    • Company Overview
    • Board
    • Corporate Directory
  • PIPELINE & TRIALS
    • Therapeutic Pipeline
    • MPL Veterinary Trial Details
    • MPL and Veterinary Trials
    • Veterinary Trial Testimonials
    • MPL and Human Trials
    • Publications
    • Pet Cancer Information Service
    • Motor Neuron Disease Trial
  • INVESTOR CENTRE
    • PhamAust AGM 2022
    • News & Announcements
    • Company Research
    • Financial Reports
    • Annual Reports
    • Investor Presentations
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • Podcast Episode 18: Dr Kim Agnew, PharmAust
    • Fireside Chat with Dr Roger Aston
    • Fireside Chat with Dr Kim
    • PharmAust Webinar
    • Epichem Webinar
    • BB PAA Video – September 2021
    • OHD Benchtop Flow Reactor Launch
    • Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
    • Interview with TechInvest – May 2020
    • Dr. Richard Mollard – 6IX Interview March 2020
    • PharmAust In the News
    • PharmAust Videos
    • PharmAust New Cancer Treatment
    • PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
    • PharmAust on Youtube
  • CONTACT
  • HOME
  • ABOUT
    • Company Overview
    • Board
    • Corporate Directory
  • PIPELINE & TRIALS
    • Therapeutic Pipeline
    • MPL Veterinary Trial Details
    • MPL and Veterinary Trials
    • Veterinary Trial Testimonials
    • MPL and Human Trials
    • Publications
    • Pet Cancer Information Service
    • Motor Neuron Disease Trial
  • INVESTOR CENTRE
    • PhamAust AGM 2022
    • News & Announcements
    • Company Research
    • Financial Reports
    • Annual Reports
    • Investor Presentations
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • Podcast Episode 18: Dr Kim Agnew, PharmAust
    • Fireside Chat with Dr Roger Aston
    • Fireside Chat with Dr Kim
    • PharmAust Webinar
    • Epichem Webinar
    • BB PAA Video – September 2021
    • OHD Benchtop Flow Reactor Launch
    • Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
    • Interview with TechInvest – May 2020
    • Dr. Richard Mollard – 6IX Interview March 2020
    • PharmAust In the News
    • PharmAust Videos
    • PharmAust New Cancer Treatment
    • PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
    • PharmAust on Youtube
  • CONTACT

Author Archives: PharmAust

2018 AGM Results

News & Announcements 2018By PharmAust09/11/2018

2018 AGM Results

2018 AGM Presentation

News & Announcements 2018By PharmAust09/11/2018

2018 AGM Presentation

Top 20 Shareholders 31st October 2018

News & Announcements 2018, Top 20 ShareholdersBy PharmAust06/11/2018

Top_Holder_-_Detail_-_Single_Date October

Drug Reformulation Play With Significant Potential

News & Announcements 2018, Research Notes 2018By PharmAust06/11/2018

2018 11 05 PharmAust report from NDF Research This report has been commissioned and paid for by PharmAust (Company) and has been prepared by NDF Research, an Authorised Representative of BR Securities Australia Pty Ltd. The report solely reflects the views of Pitt Street Research. Any opinions, forecasts, recommendations or forward-looking statements in the report…

September 2018 Appendix 4C Quarterly Report and Company Update

Financial Reports 2018, News & Announcements 2018By PharmAust01/11/2018

43zxgv0spl3ht0

GMP Method for PharmAust Analogue Pipeline

News & Announcements 2018By PharmAust29/10/2018

181029_GMP_AAD_Manufacture

PharmAust Progresses Monepantel Tablet Program for Cancer

News & Announcements 2018By PharmAust14/10/2018

181015_Tablet_Update

Notice of Annual General Meeting: November 9

News & Announcements 2018By PharmAust10/10/2018

181010_Notice of Annual Meeting

October 8, Director’s Interest

News & Announcements 2018By PharmAust08/10/2018

181008_Director's Interest_

Top 20 Shareholders October 2018

News & Announcements 2018, Top 20 ShareholdersBy PharmAust05/10/2018

top_holder_-_detail_-_single_date September

←1
23456789101112131415161718192021222324252627
…2829303132…
333435363738394041424344454647484950
51→
MENU
  • Home
  • About Us
  • Pipeline & Trials
  • Investor Centre
  • Media
  • Contact Us
SUBSCRIBE TO OUR NEWSLETTER


Facebook
Facebook
fb-share-icon
Twitter
YouTube

PharmAust Follow

PharmAust is a clinical-stage biotech company developing drug discovery IP to treat cancer, viral and neurological diseases. ASX: $PAA FSE: $ECQ

PharmAust
pharmaust PharmAust @pharmaust ·
4 Sep

Great spread on Louie the Beagle in @AustVetMag Australian Veterinarian Magazine - Spring Issue

https://simplebooklet.com/theaustralianveterinarianmagazine_spring_2023_issue21

Reply on Twitter 1698509346102010223 Retweet on Twitter 1698509346102010223 2 Like on Twitter 1698509346102010223 9 Twitter 1698509346102010223
pharmaust PharmAust @pharmaust ·
2 Sep

PharmAust CEO Dr Michael Thurn spoke with @Biotech_Buzz from @StocksDownUnder and @PSR_Insights about the clinical success with our flagship drug, Monepantel (MPL)

🎥 https://youtu.be/oCfvzseRDxQ?si=iBZu_GMBIg5oSiMX

Reply on Twitter 1697769500807176530 Retweet on Twitter 1697769500807176530 2 Like on Twitter 1697769500807176530 13 Twitter 1697769500807176530
pharmaust PharmAust @pharmaust ·
29 Aug

New CEO to take the helm as PharmAust progresses clinical studies

Reply on Twitter 1696342181496443106 Retweet on Twitter 1696342181496443106 2 Like on Twitter 1696342181496443106 7 Twitter 1696342181496443106
Load More

Copyright © 2023 PharmAust. All rights reserved.
nil

Website Design & Digital Marketing Perth by Total Click Solutions

Go to Top